Search research articles
Contact Us
Filters
Showing results (481-490 of 744) with videos related to
Page
of 75
Sort By:
Cancers
|
June 26, 2025
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted
Lukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko, et al.
The Oncologist
|
August 12, 2016
Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
Mario E Lacouture, Brigitte Dréno, Paolo Antonio Ascierto, et al.
Cancer Research Communications
|
April 24, 2023
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence
Esmee P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, et al.
Frontiers in Oncology
|
May 2, 2022
Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibition
Simon Burgermeister, Hubert S Gabryś, Lucas Basler, et al.
The Journal of Experimental Medicine
|
October 28, 2020
Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis
Min Ma, Soumitra Ghosh, Daniele Tavernari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2025
Circulating tumor DNA is prognostic of patient outcome and enables therapy monitoring in metastatic uveal melanoma
Egle Ramelyte, Julian Kött, Aleigha R Lawless, et al.
Lancet (London, England)
|
July 16, 2008
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
Alexander Mm Eggermont, Stefan Suciu, Mario Santinami, et al.
Genome Biology
|
April 18, 2015
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma
Phil F Cheng, Olga Shakhova, Daniel S Widmer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 29, 2019
Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K-mutant advanced or metastatic melanoma
Caroline Robert, Keith Flaherty, Paul Nathan, et al.
Cancers
|
August 12, 2022
Over-Detection of Melanoma-Suspect Lesions by a CE-Certified Smartphone App: Performance in Comparison to Dermatologists, 2D and 3D Convolutional Neural Networks in a Prospective Data Set of 1204 Pigmented Skin Lesions Involving Patients' Perception
Anna Sophie Jahn, Alexander Andreas Navarini, Sara Elisa Cerminara, et al.
Page
of 75
Search research articles
Search
Showing results (481-490 of 744) with videos related to
Sort By:
Page
of 75
Cancers
|
June 26, 2025
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted
Lukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko, et al.
The Oncologist
|
August 12, 2016
Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
Mario E Lacouture, Brigitte Dréno, Paolo Antonio Ascierto, et al.
Cancer Research Communications
|
April 24, 2023
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence
Esmee P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, et al.
Frontiers in Oncology
|
May 2, 2022
Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibition
Simon Burgermeister, Hubert S Gabryś, Lucas Basler, et al.
The Journal of Experimental Medicine
|
October 28, 2020
Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis
Min Ma, Soumitra Ghosh, Daniele Tavernari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2025
Circulating tumor DNA is prognostic of patient outcome and enables therapy monitoring in metastatic uveal melanoma
Egle Ramelyte, Julian Kött, Aleigha R Lawless, et al.
Lancet (London, England)
|
July 16, 2008
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
Alexander Mm Eggermont, Stefan Suciu, Mario Santinami, et al.
Genome Biology
|
April 18, 2015
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma
Phil F Cheng, Olga Shakhova, Daniel S Widmer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 29, 2019
Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K-mutant advanced or metastatic melanoma
Caroline Robert, Keith Flaherty, Paul Nathan, et al.
Cancers
|
August 12, 2022
Over-Detection of Melanoma-Suspect Lesions by a CE-Certified Smartphone App: Performance in Comparison to Dermatologists, 2D and 3D Convolutional Neural Networks in a Prospective Data Set of 1204 Pigmented Skin Lesions Involving Patients' Perception
Anna Sophie Jahn, Alexander Andreas Navarini, Sara Elisa Cerminara, et al.
Page
of 75